Literature DB >> 845273

Cryptococcal meningitis complicating systemic lupus erythematosus: two patients treated with flucytosine and amphotericin B.

D C Speller, F Fakunle, S A Cairns, M Stephens.   

Abstract

Two fatal cases of cryptococcal meningitis complicating adrenocorticosteroid-treated systemic lupus erythermatosus are reported. In one patient who was treated with flucytosine alone, after an initial period of improvement cryptococci resistant to flucytosine were isolated, and subsequent amphotericine B treatment silated, and subsequent amphotericin B treatment did not alter the progress of the disease. In the second patient, who received both drugs concurrently, resistant cryptococci did not appear and the patient recovered sufficiently to return home. Flucytosine-resistant mutants could be demonstrated in vitro in the original cryptococcal isolated from both patients. The use of flucytosine and amphotericin B in combination is discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 845273      PMCID: PMC476368          DOI: 10.1136/jcp.30.3.254

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  18 in total

1.  Replica plating and indirect selection of bacterial mutants.

Authors:  J LEDERBERG; E M LEDERBERG
Journal:  J Bacteriol       Date:  1952-03       Impact factor: 3.490

2.  Combination antifungal therapy for cryptococcal meningitis.

Authors:  J S Tobias; P F Wrigley; E Shaw
Journal:  Postgrad Med J       Date:  1976-05       Impact factor: 2.401

Review 3.  Chemotherapy of systemic mycoses (first of two parts).

Authors:  J E Bennett
Journal:  N Engl J Med       Date:  1974-01-03       Impact factor: 91.245

4.  The combined effect of 5-fluorocytosine and amphotericin B in the therapy of murine cryptococcosis.

Authors:  E R Block; J E Bennett
Journal:  Proc Soc Exp Biol Med       Date:  1973-02

Review 5.  Chemotherapy of systemic mycoses (second of two parts).

Authors:  J E Bennett
Journal:  N Engl J Med       Date:  1974-02-07       Impact factor: 91.245

6.  Pharmacokinetic studies on the oral antimycotic agent 5-fluorocytosine in individuals with normal and impaired kidney function.

Authors:  J Schönebeck; A Polak; M Fernex; H J Scholer
Journal:  Chemotherapy       Date:  1973       Impact factor: 2.544

7.  Prognostic factors in cryptococcal meningitis. A study in 111 cases.

Authors:  R D Diamond; J E Bennett
Journal:  Ann Intern Med       Date:  1974-02       Impact factor: 25.391

8.  Cryptococcal meningitis as a complication of systemic lupus erythematosus treated with systemic corticosteroids.

Authors:  J V Collins; D Tong; R G Bucknall; A P Warin
Journal:  Postgrad Med J       Date:  1972-01       Impact factor: 2.401

9.  In vitro studies of 5-fluorocytosine resistance in Candida albicans and Torulopsis glabrata.

Authors:  S Normark; J Schönebeck
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191

10.  5-fluorocytosine resistance in Cryptococcus neoformans.

Authors:  E R Block; A E Jennings; J E Bennett
Journal:  Antimicrob Agents Chemother       Date:  1973-06       Impact factor: 5.191

View more
  5 in total

1.  Cryptococcal eye disease.

Authors:  P I Condon; S I Terry; H Falconer
Journal:  Doc Ophthalmol       Date:  1977-09-30       Impact factor: 2.379

2.  Cryptococcal infections.

Authors: 
Journal:  Br Med J       Date:  1978-04-22

3.  Treating fungal infections.

Authors: 
Journal:  Br Med J       Date:  1980-03-08

4.  Therapy of fungal infections of the central nervous system.

Authors:  D C Speller
Journal:  Postgrad Med J       Date:  1979-09       Impact factor: 2.401

5.  The prevalence and mortality of cryptococcal meningitis in patients with autoimmune diseases: a systematic review and meta-analysis.

Authors:  Jing Zhao; Weipin Weng; Chunli Chen; Jie Zhang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-07-14       Impact factor: 3.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.